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Abstract
Background: Huntington's disease (HD) is a dominantly inherited, neurodegenerative disorder
due to expansion of a polymorphic trinucleotide repeat in the short arm of chromosome 4. Clinical
manifestations consist of a triad of choreic movements, cognitive decline and psychiatric syndromes
starting in the fourth to fifth decade. Psychiatric manifestations vary and may precede motor and
cognitive changes. Personality changes and depression occur most commonly. Paranoid
schizophrenia-like symptoms occur in 6% to 25% of cases.
Case report: We describe a 55 year-old woman with an 8 yearlong history of behavioural
changes, multi-thematic delusions and auditory hallucinations. History and mental state
examination were suggestive of paranoid schizophrenia. Neurological examination revealed
discrete, involuntary movements affecting her arms and trunk. Genotyping detected an expanded
allele (43 trinucleotide repeats). A three-generation-long family history of chorea and
schizophrenia-like psychosis was found.
Conclusion: HD-families have been reported in which schizophrenia-like syndromes emerged in
all or most HD-affected members long before they developed extra-pyramidal or cognitive
changes. This has been attributed to more than mere coincidence. We hypothesise that in these
families the HD gene is transmitted along with a low load of small-effect "psychosis genes" which,
in the presence of the severe cognitive changes of HD, manifest as a schizophrenia-like phenotype.
Further research is needed in order to clarify the links between genetic loading and the emergence
of psychotic symptoms in Huntington's disease.
Background
Huntington's disease is a dominantly inherited neurode-
generative, neuropsychiatric disorder first described in
1872 by George Huntington. Its prevalence in Caucasian
populations is about 1 per 10 000 individuals [1,2]. The
genetic mutation underlying this disorder has been local-
ized to the short arm of chromosome 4 and was found in
1993 to consist of an expansion and instability of a poly-
morphic trinucleotide repeat (CAG repeat) in gene IT15
[3]. Healthy individuals have around 11–35 CAG repeats
on this gene, whereas HD patients have 36 or more [4-6].
HD is characterised by selective atrophy of medium spiny
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neurons in the caudate and putamen and loss of large
neurons in the deep layers of the frontal and parietal cor-
tex [1,7]. How the HD mutation leads to these changes is
not entirely known. The protein product of the gene, hunt-
ingtin, contains abnormally long polyglutamine
sequences in its mutated form and this is thought to result
in the formation of toxic intracellular aggregates. Moreo-
ver, wild-type huntingtin seems to up-regulate the tran-
scription of neurotrophic factors crucial for neuronal
survival and loss of this function is probably central to the
neurodegenerative process of HD [8,9]. GABA and acetyl-
choline are the main neurotransmitters affected in HD.
The decrease in cholinergic activity probably explains the
deficits in memory retrieval observed in HD (7). Loss of
inhibitory GABAergic function and an increased
dopamine turnover due to selective survival of type II
spiny interneurons has been proposed as an explanation
for the emergence of psychotic symptoms in HD (7). HD
manifests clinically as a triad of choreic movements, cog-
nitive decline and psychiatric syndromes. Onset usually
occurs in the fourth to fifth decade, progressing inexora-
bly to death after 15–20 years [1,10]. An inverse relation-
ship has been consistently demonstrated between the
number of CAG repeats and age at disease onset
[5,6,10,11]. Affected offspring of HD patients often
develop the disease earlier than their parents due to
expansion of the inherited abnormal CAG repeat (antici-
pation). Anticipation seems to occur specially when the
CAG repeats are inherited through the male germ line
[5,7,11].
Psychiatric and behavioural manifestations of HD are var-
ied both in nature and time of occurrence in the course of
the disease, often evolving in the same individual [7,11-
13]. Personality changes are the most common behav-
ioural manifestation and probably will occur, eventually,
in every patient [1,2,12-15]. Apathy, irritability, aggressive
and violent behaviour are the most reported conduct
problems. Depression is the second most common psy-
chiatric disorder among HD patients, with a lifetime prev-
alence of 39%, and most studies report a four- to six fold
increase in suicide [1,12-16]. Schizophrenia-like psycho-
sis occurs in HD disease with an estimated frequency of
6% to 25%, the paranoid form being apparently the most
common type [1,2,12-14,16]. Patients with an early age at
onset of HD seem to have a greater risk of developing psy-
chosis [14,16]. In this report we are especially interested
in the association between HD and schizophrenia-like
psychotic symptoms and how this may prove relevant to
our understanding of the complex genetics of schizophre-
nia. We describe a family where all known cases of HD
developed schizophrenia-like psychosis several years
before other manifestations became evident.
Case report
(referred patient is presented firstly, followed by family
history; numbers in the headings refer to family tree in fig
1)
III-2 (referred patient)
This 55-year old retired civil servant was brought by her
family to our emergency department. She was acutely agi-
tated and had refused to leave her house or to take any
food for the previous two weeks. On mental status exam-
ination she was querulous and argumentative, with a
slightly irritable mood. She claimed that her youngest
son, a police-inspector, had ordered two disguised agents
to follow her and insisted that she had recognised them
several times in different places. She believed him to be
involved in a serious corruption affair as a consequence of
which both she and him were soon to be arrested unless
they fled the country. She also claimed that a terrible smell
came from her mouth and intestines. Although she
acknowledged not feeling the smell herself, she was abso-
lutely sure of it, as people would go away from her or shut
their windows as she walked through the streets. She
seemed to be suffering auditory hallucinations and com-
Family tree Figure 1
Family tree.  /  – Huntington patient.   – Possi-
ble (insufficient information) Huntington patient.
I-1 I-2 I-3
II-1 II-2
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plained that strangers and neighbours would shout insults
at her, even when she was home alone.
According to her family, she had been expressing an
increasing concern over the previous 8 years that micro-
phones had been installed in her car by the secret police
and that her telephone was under surveillance. These con-
cerns usually were present over periods of several weeks
alternating with relatively calmer periods. She had never
received psychiatric treatment before.
Her neurological examination revealed a mild motor
slowness and very discrete, almost imperceptible involun-
tary movements affecting her arms and trunk. Brain-CT
showed no changes. Mini Mental Status score was 23 in
30. Neuropsychological testing showed difficulty follow-
ing multi-step instructions, marked compromise of verbal
and visual memory, constructive apraxia, and slight diffi-
culties in sustained attention and executive planning. HD
genotyping revealed an expanded allele with 43 CAG
repeats and an unaffected allele with 19 repeats. Ques-
tioning of the available relatives allowed us to put
together the family tree shown below. The patient was
started on amisulpride up to 600 mg a day, with gradual
improvement of her psychotic symptoms and involuntary
movements. Cognitive difficulties remained unchanged.
III-3
This subject became mentally diseased at the age of 40,
when he developed persecutory delusions and hallucina-
tions. He went through several admissions to psychiatric
hospitals and eventually a diagnosis of schizophrenia was
reached. About five years later he progressively developed
involuntary limb movements and an unsteady gait. At 49
he was fatally overrun after falling from a sidewalk. No
HD genotyping was obtained from him.
III-5
This subject became heroin-addicted at about 17. He suf-
fered frequent depressive episodes and finally committed
suicide at the age of 28. At the time of his death he had
never suffered any psychotic episodes or neurological
symptoms.
II-2
This subject was unanimously described as a caring hus-
band and father up to the age of 36, when he unexpectedly
divorced his wife under the false belief that she had an
extramarital affair going on. Over the years he progres-
sively isolated from his family and friends and lost his job
as an agrarian engineer. At 48 schizophrenia was diag-
nosed and he was admitted to a psychiatric hospital where
he remained for several weeks. Over the following years
he gradually developed intense involuntary limb move-
ments and cognitive decline, becoming bedridden and
dependent on others. He died at 56 from a myocardial inf-
arction.
I-2
This subject, an army officer, suddenly attacked a general
during a field-parade, tearing the latter's insignias away,
shouting that he was deliberately sabotaging his career
and challenging him to a duel, which in the 1930ies was
considered eccentric enough for him to be admitted into
a psychiatric hospital. He was then in his early 30ies.
Schizophrenia was diagnosed and he eventually was sub-
mitted to pre-frontal leucotomy. After this he appears to
have become chronically depressed and ended by com-
mitting suicide about eight years after the operation.
Information is lacking regarding his precise age at the time
of operation and his neurological status at any time.
I-3
Little is known about this subject, except that she became
mentally diseased as a young woman. She died in her 60es
and was deeply demented by then. It is unknown whether
she had other neurological symptoms besides dementia at
the time of her death.
Discussion
In this family Huntington's disease was diagnosed by
molecular genetic techniques in only one patient (III-2).
In spite of the obvious limitations of collecting clinical
data retrospectively, there is enough information to allow
a sure diagnosis of HD in subjects III-3 and II-2. Although
it is unknown whether subject I-2 was suffering from any
signs of chorea at the time he committed suicide, he
almost certainly passed the HD mutation on to the next
generations, as subject I-1 is known to have died in her
mid-80es with no history of psychiatric or neurological
disease. Neither IV-1, IV-3, IV-4, nor V-1 had decided to go
through HD genotyping at the time of this publication. It
is impossible to draw any conclusions regarding subject I-
3, due to insufficient information. We thus have a HD-
family where all subjects known to have carried the dis-
ease also developed schizophrenia-like psychotic symp-
toms at least five years before neurological or cognitive
manifestations became apparent. Single HD-families have
been reported where schizophrenia-like psychiatric mani-
festations emerged in all or most HD-affected members a
considerable time before they developed extra-pyramidal
or cognitive changes [17-19]. This is in contrast with the
usual psychiatric manifestations of HD, which tend to be
highly variable within the same individual, emerge
shortly before or coincidentally with the onset of chorea
and consist predominantly of non-psychotic syndromes.
Psychotic manifestations are usually rare and non-system-
atized, and occur mostly in patients who are already
demented [12,13,20]. Such observations have raised the
question of whether certain families might develop schiz-Clinical Practice and Epidemiology in Mental Health 2006, 2:1 http://www.cpementalhealth.com/content/2/1/1
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ophreniform psychosis as a specific manifestation of a
subtype of HD.
Several hypotheses have been proposed. One possibility
would be that the children of HD patients are prone to
higher rates of psychiatric disorders in general as a conse-
quence of familiar disruption and the impending risk of
developing the disease themselves [1,15,21-24]. Some
studies did demonstrate a higher prevalence of adjust-
ment reactions, antisocial conduct or personality disor-
der, and neurotic disorders among the offspring of HD
patients, irrespective of gene-status. Prevalence rates of
schizophrenia, however, were not significantly increased
[1,21,23-25].
Another possibility is that in these families the HD gene
might causes both the extra-pyramidal/cognitive decline
syndrome and the schizophreniform disorder [17-19].
This obviously means that psychotic and non-psychotic
HD families would have to carry different HD genes,
which until now remains to be demonstrated [17-19].
CAG repeat length does not differ consistently between
psychotic and non-psychotic HD patients [6,17,18,20].
Still another possibility is that psychosis in these families
results from the co-occurrence of the HD gene and a pro-
schizophrenia gene or group of genes. The hypothesis of a
single gene in linkage disequilibrium with the HD gene
has not been demonstrated by research [17,19,26]. An
explanation more in hand with the known oligogenic
nature of "primary" schizophrenia is that the HD gene
could lower the threshold for the emergence of a schizo-
phrenic phenotype [18,19]. Put otherwise, in the presence
of a low load of small effect schizophrenia genes the HD
gene may behave as a large effect schizophrenia gene.
Although large effect schizophrenia genes or candidate
genes have not been identified, they have been postulated
to occur in high density, multiply affected schizophrenia
families [26]. A similar explanation has been proposed by
Holmes et al for their finding that variation in dopamine
receptor DRD3 (a candidate small effect gene of schizo-
phrenia) is associated with development of delusions in
Alzheimer Disease patients [27]. Assuming that schizo-
phrenia oligogenes are by definition more frequent in the
general population than schizophrenia itself, this would
explain why schizophrenia is more frequent among HD
carriers than in the general population [18]. In fact, if the
co-occurrence of schizophrenia and HD was merely due
to a coincidental accumulation of phenotypes, then the
exact opposite should be expected. For some time, family
and linkage studies on Schizophrenia and Bipolar Disor-
der suggested that these disorders might constitute two
possible phenotypes of the same polygenic disorder. After
this apparent rebirth of unitary psychosis, however, it is
now becoming increasingly clear that the two disorders
share some, albeit not all of their genetic determinants
[28-31]. Some authors suggest that the two diseases might
share one or more "psychosis genes". Interaction of this
common "psychotic background" with specific pro-schiz-
ophrenia or pro-bipolar genes would then produce either
Schizophrenia or Bipolar Disorder with psychotic symp-
toms, respectively [28,29,32,33]. The possible aggregation
of psychotic symptoms in certain HD families may shed
some light on how these hypothetical pro-schizophrenia
genes may act. If the "psychosis genes" correspond pheno-
typically to the clinical dimension hallucinations/delu-
sions, then it is possible that in these families the HD gene
may act as a pro-schizophrenia gene. This raises the inter-
esting hypothesis that pro-schizophrenia genes might
determine some form of subcortical dysfunction responsi-
ble for the dimensions thought disorganization/negative
symptoms. Association with the hallucinations/delusions
phenotype of the unspecific pro-psychosis genes would
then give rise to the full Schizophrenia syndrome. It is
highly relevant, in this regard, the demonstration of sig-
nificantly higher thought disorder scores among biologi-
cal siblings and half-siblings of adopted schizophrenic
probands when compared to the siblings of adopted
healthy probands, with similarly low rates observed
among the adoptive relatives of both groups [34].
Conclusion
Only very few cases of single HD-families have been
reported where schizophrenia-like psychiatric manifesta-
tions emerged in all or most HD-affected members long
before they developed motor or cognitive changes [17-
19].
Such families may prove a valuable models in our under-
standing of the genetics of non-organic psychosis, namely
of schizophrenia.
It must be stressed that these considerations are based on
the empirical impression that psychotic symptoms tend to
aggregate in certain HD families. This assumption is based
merely on isolated reports of single families and has not
been demonstrated objectively. Further research is needed
in order to clarify the links between genetic loading and
the emergence of psychotic symptoms in Huntington's
disease.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
BC wrote and submitted the manuscript
MX helped to draft the manuscript and reviewed pub-
lished referencesPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Clinical Practice and Epidemiology in Mental Health 2006, 2:1 http://www.cpementalhealth.com/content/2/1/1
Page 5 of 5
(page number not for citation purposes)
JG revised the manuscript critically from the neurological
point of view
The authors read and approved the final manuscript. The
authors were involved in the care of the patient described
in this case report
References
1. Watt DC, Seller A: A clinico-genetic study of psychiatric disor-
der in Huntington's chorea.  Psychol Med Suppl 1993, 23:1-46.
2. Bolt J: Huntington's Chorea in the West of Scotland.  Brit J Psy-
chiat 1970, 116:259-270.
3. Huntington's Disease Collaborative Research Group: A novel gene
containing a trinucleotide repeat that is expanded and unsta-
ble on Huntington's disease chromosomes.  Cell 1993,
72:971-983.
4. Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler
J, Squitieri F, Lin B, Bassett A, Almqvist E, Bird T, Hayden M: A
Worldwide Study of the Huntington's Disease Mutation: the
Sensitivity and Specificity of Measuring CAG Repeats.  N Engl
J Med 1994, 330:1401-1406.
5. Andrew S, Goldberg Y, Kremer B, Telenius H, Theilmann J, Adam S,
Starr E, Squitieri F, Lin B, Kalchman , Graham R, Hayden M: The rela-
tionship between trinucleotide (CAG) repeat length and
clinical features of Huntington's disease.  Nature Genetics 1993,
4:398-403.
6. Claes S, Van Zand K, Legius E, Dom R, Malfroid M, Baro F, Godderis
J, Cassiman J-J: Correlations Between Triplet Repeat Expan-
sion and Clinical Features in Huntington's Disease.  Arch Neu-
rol 1995, 113:749-753.
7. Amann B, Sterr A, Thoma H, Messer T, Kapfhammer HP, Grunze H:
Psychopathological Changes Preceding Motor Symptoms in
Huntington's Disease: A Report on Four Cases.  World J Biol
Psychiatry 2000, 1:55-58.
8. Zuccato C, Ciammola A, Rigamonti D, Leavitt B, Goffredo D, Conti
L, MacDonald M, Friedlander R, Silani V, Hayden M, Timmusk T, Sipi-
one S, Cattaneo E: Loss of Huntingtin-Mediated BDNF Gene
Transcription in Huntington's Disease.  Science 2001,
293:493-498.
9. Lecerf JM, Shirley T, Zhu Q, Kazantsev A, Amersdorfer P, Housman
D, Messer A, Huston J: Human single-chain Fv intrabodies
counteract in situ huntingtin aggregation in cellular models
of Huntington's disease.  PNAS 2001, 98(8):4764-4769.
10. MacMillan J, Snell R, Tyler A, Houlihan G, Fenton I, Cheadle J, Lazarou
L, Shaw D, Harper P: Molecular analysis and clinical correla-
tions of the Huntington's disease mutation.  Lancet 1993,
342:954-958.
11. Brooks D, Murphy D, Janota I, Lishman W: Early-onset Hunting-
ton's Chorea-Diagnostic Clues.  Brit J Psychiat 1987, 151:850-852.
12. Schiwach R: Psychopathology in Huntington's disease
patients.  Acta Psychiatr Scand 1994, 90:241-246.
13. Caine E, Shoulson I: Psychiatric syndromes in Huntington's dis-
ease.  Am J Psychiatry 1983, 140:728-733.
14. Cummings JL: Behavioural and Psychiatric Symptoms Associ-
ated with Huntington's Disease.  Advances in Neurology 1995,
65:179-186.
15. Dewhurst K, Oliver J, McKnight A: Socio-Psychiatric Conse-
quences of Huntington's Disease.  Brit J of Psychiat 1970,
116:255-258.
16. Rosenblatt A, Leroi I: Neuropsychiatry of Huntington's Disease
and Other Basal Ganglia Disorders.  Psychosomatics 2000,
41:24-30.
17. Tsuang D, DiGiacomo L, Lipe H, Bird TD: Familial Aggregation of
Schizophrenia-Like Symptoms in Huntington's Disease.  Am
J Med Genet 1998, 81:323-327.
18. Tsuang D, Almqvist EW, Lipe H, Strgar F, DiGiacomo L, Hoff D,
Eugenio C, Hayden MR, Bird TD: Familial Aggregation of Psy-
chotic Symptoms in Huntington's Disease.  Am J Psychiatry
2000, 157:1955-1959.
19. Lovestone S, Hodgson S, Sham P, Differ A-M, Levy R: Familial pres-
entation of Huntington's disease.  J Med Genet 1996, 33:128-131.
20. Zappacosta B, Monza D, Meoni C, et al.: Psychiatric symptoms do
not correlate with cognitive decline, motor symptoms, or
CAG repeat length in Huntington's disease.  Arch Neurol 1996,
53:493-497.
21. Berrios GE, Wagle AC, Marková IS, Wagle SA, Rosser A, Hodges JR:
Psychiatric symptoms in neurologically asymptomatic Hunt-
ington's disease gene carriers: a comparison with gene neg-
ative at risk subjects.  Acta Psychiatr Scand 2002, 105:224-230.
22. Jensen P, Sørensen SA, Fenger K, Bolwig TG: A Study of Psychiat-
ric Morbidity in Patients with Huntington's Disease, Their
Relatives, and Controls.  Brit J Psychiat 1993, 163:790-797.
23. Schiwach RS, Norbury CG: A Controlled Psychiatric Study of
Individuals at Risk for Huntington's Disease.  Brit J Psychiat 1994,
165:500-505.
24. Folstein SE, Franz ML, Jensen BA, Chase GA, Folstein MF: Conduct
disorder and affective disorder among the offspring of
patients with Huntington's Disease.  Psychological Medicine 1983,
13:45-52.
25. Baxter LR, Mazziotta JC, Pahl JJ, Grafton ST, St George-Hyslop P,
Haines JL, Gusella JF, Szuba MP, Selin CE, Guze BH, Phelps ME: Psy-
chiatric, Genetic, and Positron Emission Tomographic Eval-
uation of Persons at Risk for Huntington's Disease.  Arch Gen
Psychiatry 1992, 49:148-154.
26. Gordon D, Finch SJ: Finding schizophrenia genes.  J Clin Invest
2005, 115:1440-1448.
27. Holmes C, Smith H, Ganderton R, Arranz M, Collier D, Powell J,
Lovestone S: Psychosis and aggression in Alzheimer's disease:
the effect of dopamine receptor gene variation.  J Neurol Neu-
rosurg Psychiatry 2001, 71:777-779.
28. Meltzer H: Genetics and Etiology of Schizophrenia and Bipo-
lar Disorder.  Biol Psychiatry 2000, 47:171-173.
29. Berrettini W: Susceptibility Loci for Bipolar Disorder: Overlap
with Inherited Vulnerability to Schizophrenia.  Biol Psychiatry
2000, 47:245-251.
30. Cardno A, Rijsdijk F, Sham P, Murray R, McGuffin P: A Twin Study
of Genetic Relationships Between Psychotic Symptoms.  Am
J Psychiatry 2002, 159:539-545.
31. Berrettini W: Evidence for Shared Susceptibility in Bipolar
Disorder and Schizophrenia.  Am J Med Genet 2003, 123C:59-64.
32. Gershon E: Bipolar Illness and Schizohrenia as Oligogenic Dis-
eases: Implications for the Future.  Biol Psychiatry 2000,
47:240-244.
33. Potash J, Willour V, Chiu YF, Simpson S, MacKinnon D, Pearlson G,
DePaulo J, McInnis M: The Familial Aggregation of Psychotic
Symptoms in Bipolar Disorder Pedigrees.  Am J Psychiatry 2001,
158:1258-1264.
34. Kinney DK, Holzman PS, Jacobsen B, Jansson L, Faber B, Hildebrand
W, Kasell E, Zimbalist ME: Thought Disorder in Schizophrenic
and Control Adoptees and Their Relatives.  Arch Gen Psychiatry
1997, 54:475-479.